序号 |
标题 |
次数 |
作者 |
发布时间 |
62686 |
CAS: 2504147-59-3,MC (C5)-Val-Cit |
57 |
WYQ |
2024-12-19 |
62687 |
CAS: 159857-80-4,MC-Val-Cit-PAB-OH |
72 |
WYQ |
2024-12-19 |
62688 |
cas:2055024-65-0 Azido-PEG3-Val-Cit-PAB-OH |
74 |
zyl |
2024-12-19 |
62689 |
Mal-Amide-PEG4-Val-Cit-PAB-OH,ADC定制 |
52 |
wyh |
2024-12-19 |
62690 |
CAS 2249935-92-8:Mal-PEG1-Val-Cit-PAB-PNP |
82 |
WYQ |
2024-12-19 |
62691 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
77 |
zyl |
2024-12-19 |
62692 |
Alkyne-Val-Cit-PAB-OH,ADC定制 |
121 |
wyh |
2024-12-19 |
62693 |
CAS 2395887-69-9:Mal-PEG2-Val-Cit-PAB-PNP |
71 |
WYQ |
2024-12-19 |
62694 |
CAS 1438853-35-0:Mal-PEG3-Val-Cit-PAB-PNP |
58 |
WYQ |
2024-12-19 |
62695 |
N-(Methyltetrazine-PEG4)-amido-PEG8-3,4-dithiophenolmaleimide |
85 |
zyl |
2024-12-19 |
62696 |
MC-beta-Ala-alpha-GlcA-MMAE,ADC定制 |
98 |
wyh |
2024-12-19 |
62697 |
Mal-PEG2-Val-Cit-PAB-OH(CAS: 2055041-38-6) |
61 |
WYQ |
2024-12-19 |
62698 |
cas:2100306-78-1,t-Butyl 3-(hydroxypropoxyl)-propanoate |
66 |
zyl |
2024-12-19 |
62699 |
NHS ester-PEG4-VC-PAB-Daunorubicin,ADC定制 |
58 |
wyh |
2024-12-19 |
62700 |
Mal-PEG3-Val-Cit-PAB-OH(CAS: 2727965-49-1) |
91 |
WYQ |
2024-12-19 |
62701 |
cas:1539292-60-8,tert-butyl 3-(4-(2-cyanoethynyl)phenylcarbamoyl)propylcarbamate |
53 |
zyl |
2024-12-19 |
62702 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
58 |
wyh |
2024-12-19 |
62703 |
cas:34450-18-5,Alkynyl Stearic Acid,17-十八炔酸 |
98 |
zyl |
2024-12-19 |
62704 |
Mal-PEG4-Val-Cit-PAB-OH(CAS: 2055041-39-7) |
98 |
WYQ |
2024-12-19 |
62705 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
63 |
wyh |
2024-12-19 |
62706 |
cas:120550-35-8,Biotin-PFP ester,五氟苯酚生物素酯 |
195 |
zyl |
2024-12-19 |
62707 |
MTS-ADO3A 三酸DOTA衍生物 |
89 |
h |
2024-12-19 |
62708 |
NHS-PEG2-NH-Xanomeline,ADC定制 |
76 |
wyh |
2024-12-19 |
62709 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
108 |
h |
2024-12-19 |
62710 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
67 |
h |
2024-12-19 |
62711 |
cas:2123482-78-8,TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
56 |
zyl |
2024-12-19 |
62712 |
GG-Tesirine,ADC定制 |
99 |
wyh |
2024-12-19 |
62713 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
142 |
h |
2024-12-19 |
62714 |
MC-GGFG-Exatecan,ADC定制 |
110 |
wyh |
2024-12-19 |
62715 |
亲和素-AMF-DOTA(Nd) |
85 |
h |
2024-12-19 |
62716 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
86 |
h |
2024-12-19 |
62717 |
MC-VA-PBD,MC-Val-Ala-PBD,ADC定制 |
163 |
wyh |
2024-12-19 |
62718 |
cas:2241685-22-1,DADPS Biotin Alykne |
78 |
zyl |
2024-12-19 |
62719 |
MC-vc-PAB-C6-Alpha-Amanitin,ADC定制 |
61 |
wyh |
2024-12-19 |
62720 |
MPB-MMAF,ADC定制 |
115 |
wyh |
2024-12-19 |
62721 |
DOTA–Bipy–RuII配位共轭物 |
111 |
h |
2024-12-19 |
62722 |
cas:1007215-91-9,1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
99 |
zyl |
2024-12-19 |
62723 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
69 |
h |
2024-12-19 |
62724 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
80 |
h |
2024-12-19 |
62725 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
82 |
h |
2024-12-19 |
62726 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
71 |
h |
2024-12-19 |
62727 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
120 |
h |
2024-12-19 |
62728 |
DOTA-c(RGDfK)DOTA偶联环肽 |
80 |
h |
2024-12-19 |
62729 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
96 |
h |
2024-12-19 |
62730 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
82 |
h |
2024-12-19 |